Colin advises clients throughout their lifecycle (all the way from start-up/spin-out to multinational listed companies) on the commercialisation of their intellectual property rights. In particular, advising on licensing deals, collaborations and R&D projects, distribution and manufacturing and the IP, commercial and regulatory aspects of M&A, VC investments and IPOs.

Having a 1st class degree in Cell Biology his practice has naturally become focused on the life sciences, healthcare and technology (with a particular focus on med-tech and clean-tech) sectors.

显示完整简历 隐藏完整简历

最新新闻和观点

pipette
Synapse

Private equity investment in life sciences sector

30 七月 2020
IN-DEPTH ANALYSIS

作者

点击此处了解更多
scientist-with-molecule-models
酒店与休闲

Licensing out: Try not to get benched

27 七月 2020
IN-DEPTH ANALYSIS

作者 Colin McCall 以及 Justyna Ostrowska

点击此处了解更多
pipette
Synapse

Arbitration for life sciences companies

29 六月 2020
IN-DEPTH ANALYSIS

作者

点击此处了解更多
centrifuge-machine
Synapse

Territorial licensing: "start at the end before you begin"

25 六月 2020
IN-DEPTH ANALYSIS

作者 Colin McCall 以及 Justyna Ostrowska

点击此处了解更多

与我会面: